Intrinsic Value of S&P & Nasdaq Contact Us

Erasca, Inc. ERAS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.60
-35%

Erasca, Inc. (ERAS) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 8 recommend buying, 1 recommend holding, and 1 recommend selling.

The analyst consensus price target for ERAS is $11.60, representing a -35.0% downside from the current price of $17.85. Price targets range from a low of $5.00 to a high of $20.00.

Analyst Consensus — ERAS

Buy
Strong Buy
0
Buy
8
Hold
1
Sell
1
Strong Sell
0
10 analysts
Price Targets
Consensus$11.60
High$20.00
Low$5.00
Median$11.00
Last Month Avg$20.00
Last Quarter Avg$11.17
Last Year Avg$8.18
All-Time Count14
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message